- Home
- ADAP vs CEE Comparison
ADAP vs CEE Comparison
Compare ADAP & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CEE
- Stock Information
- Founded
- ADAP 2008
- CEE 1990
- Country
- ADAP United Kingdom
- CEE Germany
- Employees
- ADAP N/A
- CEE N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CEE Finance Companies
- Sector
- ADAP Health Care
- CEE Finance
- Exchange
- ADAP Nasdaq
- CEE Nasdaq
- Market Cap
- ADAP 75.5M
- CEE 107.5M
- IPO Year
- ADAP 2015
- CEE N/A
- Fundamental
- Price
- ADAP $0.29
- CEE $15.63
- Analyst Decision
- ADAP Buy
- CEE
- Analyst Count
- ADAP 6
- CEE 0
- Target Price
- ADAP $1.52
- CEE N/A
- AVG Volume (30 Days)
- ADAP 1.6M
- CEE 22.0K
- Earning Date
- ADAP 05-13-2025
- CEE 01-01-0001
- Dividend Yield
- ADAP N/A
- CEE 3.86%
- EPS Growth
- ADAP N/A
- CEE N/A
- EPS
- ADAP N/A
- CEE N/A
- Revenue
- ADAP $179,639,000.00
- CEE N/A
- Revenue This Year
- ADAP N/A
- CEE N/A
- Revenue Next Year
- ADAP $52.49
- CEE N/A
- P/E Ratio
- ADAP N/A
- CEE N/A
- Revenue Growth
- ADAP 878.53
- CEE N/A
- 52 Week Low
- ADAP $0.20
- CEE $7.80
- 52 Week High
- ADAP $1.48
- CEE $10.32
- Technical
- Relative Strength Index (RSI)
- ADAP 53.94
- CEE 56.23
- Support Level
- ADAP $0.26
- CEE $15.20
- Resistance Level
- ADAP $0.30
- CEE $15.90
- Average True Range (ATR)
- ADAP 0.03
- CEE 0.55
- MACD
- ADAP 0.00
- CEE -0.04
- Stochastic Oscillator
- ADAP 58.12
- CEE 27.91
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.